187 related articles for article (PubMed ID: 23327734)
1. Tissue engineering/regenerative medicine ventures should invest early in market research to understand the future market's needs.
Gemmiti C
Tissue Eng Part B Rev; 2013 Apr; 19(2):97-8. PubMed ID: 23327734
[No Abstract] [Full Text] [Related]
2. Regenerative medicine 2.0.
Mason C
Regen Med; 2007 Jan; 2(1):11-8. PubMed ID: 17465770
[No Abstract] [Full Text] [Related]
3. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
[TBL] [Abstract][Full Text] [Related]
4. [Collaboration between academia and companies].
Ueda M
Nihon Rinsho; 2008 May; 66(5):997-1002. PubMed ID: 18464523
[TBL] [Abstract][Full Text] [Related]
5. [Social effects in regenerative medicine].
Miyake J
Nihon Rinsho; 2008 May; 66(5):1004-12. PubMed ID: 18464524
[TBL] [Abstract][Full Text] [Related]
6. Regenerative medicine and the developing world.
Greenwood HL; Singer PA; Downey GP; Martin DK; Thorsteinsdóttir H; Daar AS
PLoS Med; 2006 Sep; 3(9):e381. PubMed ID: 16968130
[TBL] [Abstract][Full Text] [Related]
7. The Netherlands advancing to the forefront of regenerative medicine.
Gielen K
Stem Cells Dev; 2014 Dec; 23 Suppl 1():29-31. PubMed ID: 25457958
[TBL] [Abstract][Full Text] [Related]
8. Reimbursement and adoption of advanced therapies: the 5-C framework.
Malik NN
Regen Med; 2014; 9(5):573-8. PubMed ID: 25372076
[No Abstract] [Full Text] [Related]
9. The dangers in adopting a tissue-engineering-centric agenda: a president's perspective.
Gilbert JL
J Biomed Mater Res A; 2011 Feb; 96(2):273-4. PubMed ID: 21171146
[No Abstract] [Full Text] [Related]
10. A change in the market--investing in diagnostics.
Batchelder K; Miller P
Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
[No Abstract] [Full Text] [Related]
11. Translational regenerative medicine research: essential to discovery and outcome.
Mason C; Dunnill P
Regen Med; 2007 May; 2(3):227-9. PubMed ID: 17511558
[No Abstract] [Full Text] [Related]
12. Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.
Johnson S
Stem Cells Dev; 2013 Dec; 22 Suppl 1():85-8. PubMed ID: 24304082
[No Abstract] [Full Text] [Related]
13. Regenerative medicine: the emergence of an industry.
Nerem RM
J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S771-5. PubMed ID: 20843840
[TBL] [Abstract][Full Text] [Related]
14. An Overview of the Tissue Engineering Market in the United States from 2011 to 2018.
Kim YS; Smoak MM; Melchiorri AJ; Mikos AG
Tissue Eng Part A; 2019 Jan; 25(1-2):1-8. PubMed ID: 30027831
[TBL] [Abstract][Full Text] [Related]
15. In the Spotlight: Tissue and Molecular Engineering.
Desai TA
IEEE Rev Biomed Eng; 2008; 1():21-2. PubMed ID: 22274897
[TBL] [Abstract][Full Text] [Related]
16. Lancet Commission: Stem cells and regenerative medicine.
Cossu G; Birchall M; Brown T; De Coppi P; Culme-Seymour E; Gibbon S; Hitchcock J; Mason C; Montgomery J; Morris S; Muntoni F; Napier D; Owji N; Prasad A; Round J; Saprai P; Stilgoe J; Thrasher A; Wilson J
Lancet; 2018 Mar; 391(10123):883-910. PubMed ID: 28987452
[No Abstract] [Full Text] [Related]
17. Interview. The story of Advanced BioHealing: commercializing bioengineered tissue products. Mr Tozer speaks to Emily Culme-Seymour, Assistant Commissioning Editor.
Tozer D
Regen Med; 2011 Mar; 6(2):157-61. PubMed ID: 21391848
[TBL] [Abstract][Full Text] [Related]
18. [The industrialization of regenerative medicine--a potential market of $ 500 billion].
Gu Q; Zhang X; Jiang L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Sep; 21(9):1011-5. PubMed ID: 17933243
[TBL] [Abstract][Full Text] [Related]
19. [Update on tissue engineering: propagation of regenerative medicine for bone and cartilage].
Takato T
Clin Calcium; 2008 Dec; 18(12):1683. PubMed ID: 19165974
[No Abstract] [Full Text] [Related]
20. Advanced processing routes for tissue engineering and regenerative medicine.
Jayasinghe SN
Biomed Mater; 2008 Sep; 3(3):030201. PubMed ID: 18711253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
